Comparable stake leader
Forbion Growth Opportunities Fund II Cooperatief U.A.
SEC ownership of BICYCLE THERAPEUTICS PLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001761612.
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- BCYC on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Forbion Growth Opportunities Fund II Cooperatief U.A.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Forbion Growth Opportunities Fund II Cooperatief U.A.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001761612
- Issuer location
- Cambridge, United Kingdom
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BICYCLE THERAPEUTICS PLC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Forbion Growth Opportunit...
Disclosed value leader
BAKER BROS. ADVISORS LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.3%
13D/G row: Forbion Growth Opportunities Fund II Cooperatief U.A.
Showing 1-8 of 50 holder rows.
Quick read
Forbion Growth Opportunities Fund II Cooperatief U.A. leads the comparable SEC ownership view at 7.3%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Forbion Growth Opportunities Fund II Cooperatief U.A.'s linked filing trail.
Comparable ownership
Top 5
Forbion Growth Opportunities Fund...
7.3%
ARMISTICE CAPITAL, LLC
6.7%
Long Focus Capital Management, LLC
6.6%
Point72 Asset Management, L.P.
3.9%
Invus Global Management, LLC
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund II Cooperatief U.A. |
13D/G
|
7.3%
|
$28,343,629
3,452,330 shares
|
$0 | 21 Nov 2024 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
6.7%
|
$14,543,440
3,398,000 shares
|
$0 | 30 Jun 2026 |
| Long Focus Capital Management, LLC |
13D/G
13F
Company
|
6.6%
|
$16,487,221
3,310,687 shares
|
$0 | 31 Mar 2026 |
| Point72 Asset Management, L.P. |
13D/G
13F
Company
|
3.9%
|
$14,882,536
1,860,317 shares
|
-$15,032,008 | 30 Jun 2025 |
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
3.1%
|
$7,773,192
1,560,882 shares
|
-$7,909,072 | 31 Mar 2026 |
| Deep Track Capital, LP |
13D/G
|
2.4%
|
$9,625,952
1,203,244 shares
|
-$12,943,416 | 30 Jun 2025 |
| BAKER BROS. ADVISORS LP |
3/4/5
13F
Director, 10%+ Owner · Company
|
22%
from 13F
|
$153,412,999
10,056,674 shares
mixed-class rows
|
— | 02 Jan 2026 |
| FCPM III SERVICES B.V. |
13F
Company
|
6.9%
|
$14,706,143
3,468,430 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$551,656.
Buys
$0
Insiders: 0
Sells
$551,656
Insiders: 8
Net
-$551,656
Shares: -88,883
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 88,883
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 14,129 | $0 | $60,461 | -$60,461 |
| 3-6 | 0 | 14,168 | $0 | $69,977 | -$69,977 |
| 6-9 | 0 | 49,534 | $0 | $328,256 | -$328,256 |
| 9-12 | 0 | 11,052 | $0 | $92,962 | -$92,962 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 26 reporting-owner rows connected to BICYCLE THERAPEUTICS PLC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
26
Largest Forms 3/4/5 holder
BAKER BROS. ADVISORS LP
Net 12M change
-$551,656
Latest report
15 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Director, 10%+ Owner | $153,412,999 | Mixed | 02 Jan 2026 | ||
| Kate Bingham | Director | $32,731,633 | Mixed | 13 Jul 2021 | ||
| Kevin Lee | CHIEF EXECUTIVE OFFICER, Director | $2,601,822 | -$258,045 | -9% | Filing P/S | 02 Jul 2026 |
| Gregory Paul Winter | Director | $1,390,722 | Mixed | 02 Jan 2026 | ||
| Nicholas Keen | Chief Scientific Officer | $1,355,631 | Mixed | 03 Jul 2024 | ||
| Santiago Arroyo | Chief Development Officer | $973,013 | Filing P/S | 02 Jan 2025 | ||
| Alistair Milnes | Chief Operating Officer | $883,191 | -$61,986 | -6.6% | Filing P/S | 02 Jan 2026 |
| Nigel Crockett | Chief Business Officer | $753,032 | Filing P/S | 02 Jan 2025 | ||
| Pierre Legault | Director | $690,000 | Mixed | 02 Jan 2025 | ||
| Michael Skynner | Chief Scientific Officer | $677,407 | -$79,059 | -10% | Filing P/S | 15 Jul 2026 |
| Dominic Smethurst | Chief Medical Officer | $642,233 | Mixed | 03 Jan 2023 | ||
| Richard N. Kender | Director | $570,860 | Mixed | 02 Jan 2025 | ||
| Alethia Young | Chief Financial Officer | $569,509 | -$54,592 | -8.7% | Filing P/S | 02 Jan 2026 |
| Lee Kalowski | President and CFO | $530,408 | Mixed | 03 Apr 2023 | ||
| Michael Charles Ferguson Hannay | Chief Prod & Supply Chain Off | $406,756 | -$56,832 | -12% | Filing P/S | 15 Jul 2026 |
| Jennifer Scott Perry | Chief Operating Officer | $395,165 | -$13,016 | -3.2% | Filing P/S | 15 Jul 2026 |
| Veronica Gh Jordan | Director | $293,125 | Mixed | 02 Jan 2024 | ||
| Travis Alvin Thompson | Chief Financial Officer | $277,740 | -$27,254 | -8.9% | Filing P/S | 15 Jul 2026 |
| Janice Bourque | Director | $230,103 | Mixed | 02 Jan 2026 | ||
| Jose-Carlos Gutierrez-Ramos | Director | $230,103 | Mixed | 02 Jan 2026 |
Recent insider transactions for BICYCLE THERAPEUTICS PLC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Travis Alvin Thompson | BCYC | Employee Stock Option (right to buy) | Award | 60,000 | 60,000 | 15 Jul 2026 | Direct | |||
| Michael Charles Ferguson Hannay | BCYC | Employee Stock Option (right to buy) | Award | 60,000 | 60,000 | 15 Jul 2026 | Direct | |||
| Michael Skynner | BCYC | Employee Stock Option (right to buy) | Award | 60,000 | 60,000 | 15 Jul 2026 | Direct | |||
| Jennifer Scott Perry | BCYC | Employee Stock Option (right to buy) | Award | 60,000 | 60,000 | 15 Jul 2026 | Direct | |||
| Jennifer Scott Perry | BCYC | Ordinary Shares | Sale | -0.41% | $1,631 | $4.34 | -376 | 91,052 | 06 Jul 2026 | Direct |
| Michael Skynner | BCYC | Ordinary Shares | Sale | -0.34% | $2,293 | $4.31 | -532 | 157,171 | 06 Jul 2026 | Direct |
| Kevin Lee | BCYC | Ordinary Shares | Sale | -0.29% | $7,486 | $4.31 | -1,737 | 603,671 | 06 Jul 2026 | Direct |
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Sale | -0.27% | $1,099 | $4.31 | -255 | 94,375 | 06 Jul 2026 | Direct |
| Travis Alvin Thompson | BCYC | Ordinary Shares | Sale | -0.16% | $448 | $4.31 | -104 | 64,441 | 06 Jul 2026 | Direct |
| Jennifer Scott Perry | BCYC | Ordinary Shares | Sale | -1.12% | $4,424 | $4.27 | -1,036 | 91,428 | 02 Jul 2026 | Direct |
| Michael Skynner | BCYC | Ordinary Shares | Sale | -1.17% | $7,938 | $4.27 | -1,859 | 157,703 | 02 Jul 2026 | Direct |
| Kevin Lee | BCYC | Ordinary Shares | Sale | -0.97% | $25,214 | $4.27 | -5,905 | 605,408 | 02 Jul 2026 | Direct |
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Sale | -1.57% | $6,431 | $4.27 | -1,506 | 94,630 | 02 Jul 2026 | Direct |
| Travis Alvin Thompson | BCYC | Ordinary Shares | Sale | -1.25% | $3,497 | $4.27 | -819 | 64,545 | 02 Jul 2026 | Direct |
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Sale | -0.26% | $1,268 | $5.05 | -251 | 96,136 | 06 Apr 2026 | Direct |
| Travis Alvin Thompson | BCYC | Ordinary Shares | Sale | -0.16% | $515 | $5.05 | -102 | 65,364 | 06 Apr 2026 | Direct |
| Jennifer Scott Perry | BCYC | Ordinary Shares | Sale | -0.4% | $1,865 | $5.04 | -370 | 92,464 | 06 Apr 2026 | Direct |
| Kevin Lee | BCYC | Ordinary Shares | Sale | -0.28% | $8,666 | $5.05 | -1,716 | 611,313 | 06 Apr 2026 | Direct |
| Michael Skynner | BCYC | Ordinary Shares | Sale | -0.33% | $2,651 | $5.05 | -525 | 159,562 | 06 Apr 2026 | Direct |
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Sale | -1.55% | $7,468 | $4.91 | -1,521 | 96,387 | 02 Apr 2026 | Direct |
| Travis Alvin Thompson | BCYC | Ordinary Shares | Sale | -1.21% | $3,923 | $4.91 | -799 | 65,466 | 02 Apr 2026 | Direct |
| Jennifer Scott Perry | BCYC | Ordinary Shares | Sale | -1.11% | $5,097 | $4.91 | -1,038 | 92,834 | 02 Apr 2026 | Direct |
| Kevin Lee | BCYC | Ordinary Shares | Sale | -0.96% | $29,298 | $4.91 | -5,967 | 613,029 | 02 Apr 2026 | Direct |
| Michael Skynner | BCYC | Ordinary Shares | Sale | -1.16% | $9,226 | $4.91 | -1,879 | 160,087 | 02 Apr 2026 | Direct |
| Travis Alvin Thompson | BCYC | Employee Stock Option (right to buy) | Award | 58,000 | 58,000 | 03 Feb 2026 | Direct | |||
| Travis Alvin Thompson | BCYC | Ordinary Shares | Sale | -1.65% | $7,192 | $6.45 | -1,115 | 66,265 | 05 Jan 2026 | Direct |
| Michael Skynner | BCYC | Ordinary Shares | Sale | -1.98% | $21,098 | $6.46 | -3,266 | 161,966 | 05 Jan 2026 | Direct |
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Sale | -2.36% | $15,267 | $6.45 | -2,367 | 97,908 | 05 Jan 2026 | Direct |
| Alistair Milnes | BCYC | Ordinary Shares | Sale | -2.44% | $22,067 | $6.46 | -3,416 | 136,717 | 05 Jan 2026 | Direct |
| Alethia Young | BCYC | Ordinary Shares | Sale | -4.74% | $28,123 | $6.49 | -4,334 | 87,081 | 05 Jan 2026 | Direct |
| Kevin Lee | BCYC | Ordinary Shares | Sale | -1.74% | $70,989 | $6.46 | -10,989 | 618,996 | 05 Jan 2026 | Direct |
| Travis Alvin Thompson | BCYC | Ordinary Shares | Sale | -1.92% | $8,956 | $6.80 | -1,317 | 67,380 | 02 Jan 2026 | Direct |
| Travis Alvin Thompson | BCYC | Ordinary Shares | Award | 120.2% | 37,500 | 68,697 | 02 Jan 2026 | Direct | ||
| Travis Alvin Thompson | BCYC | Employee Stock Option (right to buy) | Award | 75,000 | 75,000 | 02 Jan 2026 | Direct | |||
| Michael Skynner | BCYC | Ordinary Shares | Sale | -1.81% | $20,706 | $6.80 | -3,045 | 165,232 | 02 Jan 2026 | Direct |
| Michael Skynner | BCYC | Ordinary Shares | Award | 42.3% | 50,000 | 168,277 | 02 Jan 2026 | Direct | ||
| Michael Skynner | BCYC | Employee Stock Option (right to buy) | Award | 100,000 | 100,000 | 02 Jan 2026 | Direct | |||
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Sale | -2.74% | $19,224 | $6.80 | -2,827 | 100,275 | 02 Jan 2026 | Direct |
| Michael Charles Ferguson Hannay | BCYC | Ordinary Shares | Award | 94.2% | 50,000 | 103,102 | 02 Jan 2026 | Direct | ||
| Michael Charles Ferguson Hannay | BCYC | Employee Stock Option (right to buy) | Award | 100,000 | 100,000 | 02 Jan 2026 | Direct | |||
| Alistair Milnes | BCYC | Ordinary Shares | Sale | -2.26% | $22,059 | $6.80 | -3,244 | 140,133 | 02 Jan 2026 | Direct |
| Alistair Milnes | BCYC | Ordinary Shares | Award | 53.6% | 50,000 | 143,377 | 02 Jan 2026 | Direct | ||
| Alistair Milnes | BCYC | Employee Stock Option (right to buy) | Award | 100,000 | 100,000 | 02 Jan 2026 | Direct | |||
| Alethia Young | BCYC | Ordinary Shares | Sale | -3.47% | $22,365 | $6.80 | -3,289 | 91,415 | 02 Jan 2026 | Direct |
| Alethia Young | BCYC | Ordinary Shares | Award | 111.8% | 50,000 | 94,704 | 02 Jan 2026 | Direct | ||
| Alethia Young | BCYC | Employee Stock Option (right to buy) | Award | 100,000 | 100,000 | 02 Jan 2026 | Direct | |||
| Kevin Lee | BCYC | Ordinary Shares | Sale | -1.61% | $70,210 | $6.80 | -10,325 | 629,985 | 02 Jan 2026 | Direct |
| Kevin Lee | BCYC | Ordinary Shares | Award | 34.7% | 165,000 | 640,310 | 02 Jan 2026 | Direct | ||
| Kevin Lee | BCYC | Employee Stock Option (right to buy) | Award | 330,000 | 330,000 | 02 Jan 2026 | Direct | |||
| Stephen H. Sands | BCYC | Ordinary Shares | Award | 54.6% | 9,500 | 26,893 | 02 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.